European Medicines Agency recommends new contra-indications and warnings for pioglitazone to reduce small increased risk of bladder cancer

View source ↗

Summary

EMA recommends new contraindications and warnings for pioglitazone to address a small increased risk of bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)